Cas 628721-45-9,Carbamic acid, 5-isoquinolinyl-, phenyl ester

628721-45-9

Post Buying Request

Basic information

Product Name: Carbamic acid, 5-isoquinolinyl-, phenyl ester
Synonyms:
CAS NO:628721-45-9
Molecular Formula: C16H12N2O2
Molecular Weight: 264.283
EINECS: N/A
Product Categories: N/A
Mol File: 628721-45-9.mol
Article Data: 10

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Carbamic acid, 5-isoquinolinyl-, phenyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Carbamic acid, 5-isoquinolinyl-, phenyl ester(628721-45-9)
EPA Substance Registry System: Carbamic acid, 5-isoquinolinyl-, phenyl ester(628721-45-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 628721-45-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

628721-45-9 Suppliers

Recommended suppliersmore

628721-45-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 628721-45-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,8,7,2 and 1 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 628721-45:
(8*6)+(7*2)+(6*8)+(5*7)+(4*2)+(3*1)+(2*4)+(1*5)=169
169 % 10 = 9
So 628721-45-9 is a valid CAS Registry Number.

628721-45-9Upstream product

628721-45-9Downstream Products

628721-45-9Relevant articles and documents

Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain

Lee, Hobin,Ahn, Songyeon,Ann, Jihyae,Ha, Heejin,Yoo, Young Dong,Kim, Young Ho,Hwang, Ji-Young,Hur, Kwang-Hyun,Jang, Choon-Gon,Pearce, Larry V.,Esch, Timothy E.,Lewin, Nancy E.,Blumberg, Peter M.,Lee, Jeewoo

, (2019/09/03)

In order to discover a novel type of analgesic, we investigated dual activity ligands with TRPV1 antagonism and mu-opioid receptor affinity with the goal of eliciting synergistic analgesia while avoiding the side effects associated with single targeting.

SUBSTITUTED OXAZOLE- AND THIAZOLE-BASED CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS II

-

Page/Page column 38; 40, (2016/06/14)

The invention relates to oxazole and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE

-

Page/Page column 30-31, (2010/07/02)

Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis).

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 628721-45-9